Innovating.works Conecta tu I+D

Showing 1 to 20 of 38 results

AHEAD: AI for Health Evaluation of Applications Datasets The proliferation of Artificial Intelligence (AI) is on the rise, and yet, there remains a lack of consensus on standardised approaches for...
2024-08-22 - 2028-12-31 | Financiado

PREDICTOM: PREDICTION OF ALZHEIMER S DISEASE USING AN AI DRIVEN SCREENING PLATFORM STICHTING LYGATURE participó en un HORIZON EUROPE: HORIZON-JU-IHI-2022-03-single-stage Alzheimer’s disease (AD) and related disorders leading to dementia are associated with staggering costs and suffering. Recently, there has b...
2023-10-30 - 2027-10-31 | Financiado

IDERHA: Integration of heterogeneous Data and Evidence towards Regulatory and HTA Acceptance STICHTING LYGATURE participó en un HORIZON EUROPE: HORIZON-JU-IHI-2022-01-single-stage IDERHA will address the key obstacles to achieving appropriate access, sharing, use and reuse of lung cancer data, and thus enable enhanced...
2023-05-10 - 2028-03-31 | Financiado

EOSC4Cancer: A European wide foundation to accelerate Data driven Cancer Research STICHTING LYGATURE participó en un HORIZON EUROPE: HORIZON-INFRA-2021-EOSC-01 Cancer complex nature requires integration of advanced research data across national boundaries to enable progress. Indeed, the Horizon Euro...
2022-06-09 - 2025-02-28 | Financiado

DELIVER: Deliberative improvement of oral care quality STICHTING LYGATURE participó en un HORIZON EUROPE: HORIZON-HLTH-2021-CARE-05 Oral diseases and conditions affect more than 3.5 billion people worldwide. They are the 3rd most expensive diseases to treat in the EU and...
2022-05-18 - 2026-07-31 | Financiado

BY-COVID: Beyond COVID STICHTING LYGATURE participó en un HORIZON EUROPE: HORIZON-INFRA-2021-EMERGENCY-01 Beyond-COVID (BY-COVID) aims to provide comprehensive open data on SARS-CoV-2, and other infectious diseases across scientific, medical, pub...
2022-02-23 - 2024-09-30 | Financiado

EPND: European platform for neurodegenerative disorders STICHTING LYGATURE participó en un H2020: H2020-JTI-IMI2-2020-23-two-stage Alzheimer’s disease (AD) and Parkinson’s disease (PD) are common neurodegenerative conditions, posing a major societal burden. There is a la...
2021-10-25 - 2026-10-31 | Financiado

UNITE4TB: ACADEMIA AND INDUSTRY UNITED INNOVATION AND TREATMENT FOR TUBERCULOSIS STICHTING LYGATURE participó en un H2020: H2020-JTI-IMI2-2020-20-two-stage Current anti-tuberculosis (TB) drug regimens face serious limitations at times of increasing antimicrobial drug resistance. Fortunately, for...
2021-06-29 - 2028-05-31 | Financiado

PERSIST-SEQ: Building a reproducible single cell experimental workflow to capture tumour cell persistence STICHTING LYGATURE participó en un H2020: H2020-JTI-IMI2-2020-20-two-stage It is the ambition of PRESIST-SEQ to provide a new gold standard in single-cell experimental workflows the cancer research community by deve...
2021-06-28 - 2026-06-30 | Financiado

BIGPICTURE: Central Repository for Digital Pathology STICHTING LYGATURE participó en un H2020: H2020-JTI-IMI2-2019-18-two-stage BIGPICTURE, a pathology-led consortium, has the vision to become the catalyst in digital transformation in Pathology. Our mission is to crea...
2020-11-26 - 2027-01-31 | Financiado

B1MG: Beyond 1M Genomes STICHTING LYGATURE participó en un H2020: H2020-SC1-DTH-2018-2020 The Beyond 1 Million Genomes (B1MG) consortium will establish the support and coordination structure for the European 1+ Million Genomes ini...
2020-06-04 - 2023-10-31 | Financiado

IDEA-FAST: Identifying Digital Endpoints to Assess FAtigue Sleep and acTivities in daily living in Neurodegene... STICHTING LYGATURE participó en un H2020: H2020-JTI-IMI2-2018-15-two-stage Fatigue and sleep disturbances are two common and disabling symptoms that affect patients with neurodegenerative disorders (NDD) and immune-...
2019-12-18 - 2026-04-30 | Financiado

HEAP: Human Exposome Assessment Platform STICHTING LYGATURE participó en un H2020: H2020-SC1-BHC-2018-2020 HEAP will provide a research resource for the integrated and efficient analysis of the human exposome. One primary outcome of the project is...
2019-12-06 - 2024-12-31 | Financiado

Immune-Image: Immune Image Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies STICHTING LYGATURE participó en un H2020: H2020-JTI-IMI2-2018-14-two-stage Immunotherapies have emerged as effective treatments for immune system-related diseases, such as cancer and inflammatory diseases. Although...
2019-09-26 - 2026-03-31 | Financiado

Trials@Home: Trials@Home Center of Excellence Remote Decentralised Clinical Trials STICHTING LYGATURE participó en un H2020: H2020-JTI-IMI2-2018-14-two-stage Clinical trials increase in size, complexity and costs. This is fuelled with the need to demonstrate effects in more complex therapeutic are...
2019-08-07 - 2025-11-30 | Financiado

GNA NOW: NOVEL GRAM NEGATIVE ANTIBIOTIC NOW STICHTING LYGATURE tramitó un H2020: H2020-JTI-IMI2-2018-16-single-stage AntiMicrobial Resistance (AMR) is a global and serious threat to human health. Gram-negative bacteria are widely regarded as the culprit rep...
2019-06-17 - 2025-12-31 | Financiado

PD-MIND: Parkinson Disease with Mild cognition Impairment treated with Nicotinic agonist Drug STICHTING LYGATURE participó en un H2020: H2020-JTI-IMI2-2017-13-two-stage Parkinson Disease (PD) is the second most common neurodegenerative disease after Alzheimer’s disease. There is an unmet clinical need to tre...
2019-04-29 - 2022-04-30 | Financiado

ESCulab: European Screening Centre Unique Library for Attractive Biology STICHTING LYGATURE tramitó un H2020: H2020-JTI-IMI2-2017-12-two-stage By bridging an important gap between basic research and drug development, ESCulab will facilitate the translation of fundamental scientific...
2018-12-18 - 2023-11-30 | Financiado

FAIRplus: FAIRplus STICHTING LYGATURE participó en un H2020: H2020-JTI-IMI2-2017-12-two-stage Wide sharing of knowledge and data drives the progression of science. Shared data allows other researchers to reproduce findings and benchma...
2018-12-18 - 2022-12-31 | Financiado

FOUNDATION LYGATURE